Literature DB >> 204012

Dual actions of substance P on nociception: possible role of endogenous opioids.

R C Frederickson, V Burgis, C E Harrell, J D Edwards.   

Abstract

Substance P produces analgesia when administered to mice in very small doses by the intraventricular route (1.25 to 5 nanograms per mouse). The analgesic effect can be blocked by naloxone. At higher doses (greater than 50 nanograms per mouse), this activity is lost. At these higher doses, however, substance P produced hyperalgesia when combined with naloxone and analgesia when combined with baclofen [beta-(4-chlorophenyl)-gamma-aminobutyric acid]. Substance P may have dual actions in brain, releasing endorphins at very low doses and directly exciting neuronal activity in nociceptive pathways at higher doses.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 204012     DOI: 10.1126/science.204012

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  17 in total

1.  Substance P markedly potentiates the antinociceptive effects of morphine sulfate administered at the spinal level.

Authors:  R M Kream; T Kato; H Shimonaka; J E Marchand; W H Wurm
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

2.  Effects of intrathecal and intracerebroventricular injections of substance P on nociception in the rat and mouse [proceedings].

Authors:  A G Hayes; M B Tyers
Journal:  Br J Pharmacol       Date:  1979-07       Impact factor: 8.739

3.  Differential effects of substance P on serotonin-modulated spinal nociceptive reflexes.

Authors:  R M Murphy; F P Zemlan
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  A substance P-opioid chimeric peptide as a unique nontolerance-forming analgesic.

Authors:  S E Foran; D B Carr; A W Lipkowski; I Maszczynska; J E Marchand; A Misicka; M Beinborn; A S Kopin; R M Kream
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

5.  Failure of substance P to produce analgesia in the mouse [proceedings].

Authors:  J W Growcott; J S Shaw
Journal:  Br J Pharmacol       Date:  1979-05       Impact factor: 8.739

6.  Y-maze behavior after an analog of ACTH 4--9, evidence for an attentional alteration.

Authors:  R J Katz; R Chudler
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

Review 7.  Newer neurotransmitters in pain control.

Authors:  N Trieger
Journal:  Anesth Prog       Date:  1979 May-Jun

8.  Alterations in nociception and body temperature after intracisternal administration of neurotensin, beta-endorphin, other endogenous peptides, and morphine.

Authors:  C B Nemeroff; A J Osbahr; P J Manberg; G N Ervin; A J Prange
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

9.  Substance P drives endocannabinoid-mediated disinhibition in a midbrain descending analgesic pathway.

Authors:  Geoffrey M Drew; Benjamin K Lau; Christopher W Vaughan
Journal:  J Neurosci       Date:  2009-06-03       Impact factor: 6.167

10.  Intrathecal substance P depresses the tail-flick response - antagonism by naloxone.

Authors:  T Doi; I Jurna
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-09       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.